Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Lenalidomide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 52,329Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Changzhou Pharmaceutical Factory
    China
    		 Sampoong Pharmachem Co., Ltd. No. 582-13-ND Lenalidomide 2023-11-27 Changzhou Pharmaceutical Factory China No.518 Laodong East Road, Changzhou, Jiangsu Province, PR China
    28/09/2024 Cipla
    India
    		 Chong Kun Dang Co., Ltd. No. 496-23-ND(1) Lenalidomide hemihydrate 2017-12-08 Cipla Limited India Plot No 285,286,287, KIADB 4th Phase, Industrial Area, Bommasandra-jigani Link Road, Bangalore-560105, India